Molecular epidemiology of Hepatitis C Virus (HCV) in liver disease patients in Sri Lanka

Background: Globally, hepatitis C virus (HCV) is an important cause of chronic liver disease. Genotypes of HCV are associated with different profiles of pathogenicity, infectivity, and antiviral therapy. The prevalence of HCV and distribution of HCV genotypes in Sri Lanka in comparison with the rest...

Full description

Bibliographic Details
Main Author: D. B. Senevirathna
Format: Article
Language:English
Published: Manipal College of Medical Sciences, Pokhara 2014-11-01
Series:Asian Journal of Medical Sciences
Subjects:
Online Access:https://www.nepjol.info/index.php/AJMS/article/view/10741
id doaj-79badb699683495985201fb29e26d087
record_format Article
spelling doaj-79badb699683495985201fb29e26d0872020-11-25T03:00:09ZengManipal College of Medical Sciences, PokharaAsian Journal of Medical Sciences2467-91002091-05762014-11-016315Molecular epidemiology of Hepatitis C Virus (HCV) in liver disease patients in Sri LankaD. B. Senevirathna0 Genetech Molecular Diagnostics and School of Gene Technology, ColomboBackground: Globally, hepatitis C virus (HCV) is an important cause of chronic liver disease. Genotypes of HCV are associated with different profiles of pathogenicity, infectivity, and antiviral therapy. The prevalence of HCV and distribution of HCV genotypes in Sri Lanka in comparison with the rest of Asia is not well known. Objective: The objective of the study was to investigate the presence of HCV and to genotype HCV in a group of Sri Lankan patients suspected to have liver disease. Methods: A total of 1933 samples were screened for HCV antibodies using ELISA and HCV RNA with RT-PCR methods. RNA positive samples were genotyped by type specific amplification and by DNA sequencing. Results: Out Of the 1933 liver disease patients tested 219 (11.33%) were detected to be positive for anti-HCV antibodies, out of which, 54 (24.66%) were positive for HCV RNA. Furthermore out of 49 positively tested patients, 24 (48.97%) were found to be categorised as HCV genotype 1. Conclusion: This result confirms previous observations that the contribution of HCV as a causative virus in liver disease patients is low in Sri Lanka. HCV genotype 1 was found to be the most predominant genotype in studied cohort of Sri Lankan liver disease patients.https://www.nepjol.info/index.php/AJMS/article/view/10741liver diseaseshepacivirusgenotype
collection DOAJ
language English
format Article
sources DOAJ
author D. B. Senevirathna
spellingShingle D. B. Senevirathna
Molecular epidemiology of Hepatitis C Virus (HCV) in liver disease patients in Sri Lanka
Asian Journal of Medical Sciences
liver diseases
hepacivirus
genotype
author_facet D. B. Senevirathna
author_sort D. B. Senevirathna
title Molecular epidemiology of Hepatitis C Virus (HCV) in liver disease patients in Sri Lanka
title_short Molecular epidemiology of Hepatitis C Virus (HCV) in liver disease patients in Sri Lanka
title_full Molecular epidemiology of Hepatitis C Virus (HCV) in liver disease patients in Sri Lanka
title_fullStr Molecular epidemiology of Hepatitis C Virus (HCV) in liver disease patients in Sri Lanka
title_full_unstemmed Molecular epidemiology of Hepatitis C Virus (HCV) in liver disease patients in Sri Lanka
title_sort molecular epidemiology of hepatitis c virus (hcv) in liver disease patients in sri lanka
publisher Manipal College of Medical Sciences, Pokhara
series Asian Journal of Medical Sciences
issn 2467-9100
2091-0576
publishDate 2014-11-01
description Background: Globally, hepatitis C virus (HCV) is an important cause of chronic liver disease. Genotypes of HCV are associated with different profiles of pathogenicity, infectivity, and antiviral therapy. The prevalence of HCV and distribution of HCV genotypes in Sri Lanka in comparison with the rest of Asia is not well known. Objective: The objective of the study was to investigate the presence of HCV and to genotype HCV in a group of Sri Lankan patients suspected to have liver disease. Methods: A total of 1933 samples were screened for HCV antibodies using ELISA and HCV RNA with RT-PCR methods. RNA positive samples were genotyped by type specific amplification and by DNA sequencing. Results: Out Of the 1933 liver disease patients tested 219 (11.33%) were detected to be positive for anti-HCV antibodies, out of which, 54 (24.66%) were positive for HCV RNA. Furthermore out of 49 positively tested patients, 24 (48.97%) were found to be categorised as HCV genotype 1. Conclusion: This result confirms previous observations that the contribution of HCV as a causative virus in liver disease patients is low in Sri Lanka. HCV genotype 1 was found to be the most predominant genotype in studied cohort of Sri Lankan liver disease patients.
topic liver diseases
hepacivirus
genotype
url https://www.nepjol.info/index.php/AJMS/article/view/10741
work_keys_str_mv AT dbsenevirathna molecularepidemiologyofhepatitiscvirushcvinliverdiseasepatientsinsrilanka
_version_ 1724698971123744768